Red clover (Trifolium pratense)

Encyclopedia of Dietary Supplements

Volumn , Issue , 2004, Pages 587-602

  Booth, Nancy L ^a   Piersen, Colleen E ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84887935157     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1081/E-EDS-120022126     Document Type: Chapter

References (43)

1. Felter, H.W.; Lloyd, J.U. King’s American Dispensatory; 18th Ed.; 3rd Rev.; The Ohio Valley Company: Cincinnati, 1900; Vol. II, 1995–1996.
2. Gathercoal, E.N.; Wirth, E.H. Pharmacognosy; Lea and Febiger: Philadelphia, 1936; 372–373.
3. Hamel, P.B.; Chiltoskey, M.U. Cherokee Plants: Their Uses—A 400 Year History; Herald Publishing Company: Sylva, NC, 1975; 29.
4. Barnes, S. Phyto-oestrogens and osteoporosis: what is a safe dose? Br. J. Nutr. 2003, 89 (Suppl. 1), S101–S108.
5. Pike, A.C.; Brzozowski, A.M.; Hubbard, R.E.; Bonn, T.; Thorsell, A.G.; Engstrom, O.; Ljunggren, J.; Gustafsson, J.A.; Carlquist, M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J. 1999, 18 (17), 4608–4618.
6. Piersen, C.E. Phytoestrogens in botanical dietary supplements: implications for cancer. Int. Cancer Ther. 2003, 2 (2), 120–138.
7. Zava, D.T.; Dollbaum, C.M.; Blen, M. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc. Soc. Exp. Biol. Med. 1998, 217 (3), 369–378.
8. Kirk, C.J.; Harris, R.M.; Wood, D.M.; Waring, R.H.; Hughes, P.J. Do dietary phytoestrogens influence susceptibility to hormone-dependent cancer by disrupting the metabolism of endogenous oestrogens? Biochem. Soc. Trans. 2001, 29 (Part 2), 209–216.
9. Adlercreutz, H. Phyto-oestrogens and cancer. Lancet Oncol. 2002, 3 (6), 364-373.
10. Ren, M.Q.; Kuhn, G.; Wegner, J.; Chen, J. Isofla-vones, substances with multi-biological and clinical properties. Eur. J. Nutr. 2001, 40 (4), 135-146.
11. Yellayi, S.; Zakroczymski, M.A.; Selvaraj, V.; Valli, V.E.; Ghanta, V.; Helferich, W.G.; Cooke, P.S. The phytoestrogen genistein suppresses cell-mediated immunity in mice. J. Endocrinol. 2003, 176 (2), 267–274.
12. Doerge, D.R.; Chang, H.C. Inactivation of thyroid peroxidase by soy isoflavones, in vitro and in vivo. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002, 777 (1-2), 269-279.
13. Vaskilenko, Y.K.; Dorofeenko, G.N.; Kazakov, A.L.; Lisevitskaya, L.I.; Leont’eva, T.P.; Mezheritskii, V.V.; Parfent’eve, E.P.; Shinkarenko, A.L. Effects of red clover flavonoids and some of their synthetic analogs on lipid metabolism indexes in animals with experimental arteriosclerosis. Izvestiya Severo-Kavkazskogo Nauch-nogo Tsentra Vysshei Shkoly, Estestvennye Nauki 1978, 6 (4), 99-101.
14. Atkinson, C; Warren, R.M.L.; Sala, E.; Dowsett, M.; Dunning, A.M.; Healey, C.S.; Runswick, S.; Day, N.E.; Bingham, S.A. Red-clover derived isoflavones and mammographic breast density: A double-blind, randomized, placebo-controlled trail. Breast Cancer Res. 2004, 6, R170-R179.
15. Tice, J.A.; Ettinger, B.; Ensrud, K.; Wallace, R.; Blackwell, T.; Cummings, S.R. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study, a randomized controlled trial. JAMA 2003, 290 (2), 207-214.
16. van de Weijer, P.H.M.; Barentsen, R. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002, 42, 187-193.
17. Ingram, D.M.; Hickling, C; West, L.; Mahe, L.J.; Dunbar, P.M. A double-blind randomized controlled trial of isoflavones in the treatment of cyclical mastalgia. Breast 2002, 11, 170-174.
18. Hale, G.E.; Hughes, C.L.; Robboy, S.J.; Agarwal, S.K.; Bievre, M. A double-blind randomized study on the effects of red clover isoflavones on the endometrium. Menopause 2001, 8, 338-346.
19. Horn-Ross, P.L.; John, E.M.; Canchola, A.J.; Stewart, S.L.; Lee, M.M. Phytoestrogen intake and endometrial cancer risk. J. Natl. Cancer Inst. 2003, 95, 1158-1164.
20. Jarred, R.A.; Keikha, M.; Dowling, C; McPherson, S.J.; Clare, A.M.; Husband, A.J.; Pedersen, J.S.; Frydenberg, M.; Risbridger, G.P. Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. Cancer Epidemiol. Biomar-kers Prev. 2002, 11, 1689–1696.
21. Atkinson, C.; Compston, J.E.; Day, N.E.; Dowsett, M.; Bingham, S.A. The effects of phyto-estrogen isoflavones on bone density in women: A double-blind, randomized, placebo-controlled trail. Am. J. Clin. Nutr. 2004, 79, 326–333.
22. Kelly, G.E.; Husband, A.J. Cardiovascular and bone treatment using isoflavones. PCT Int. Appl. WO 00/64438, PCT/AU00/00384, 2000.
23. Clifton-Bligh, P.B.; Baber, R.J.; Fulcher, G.R.; Nery, M.-L.; Moreton, T. The effect of isofla-vones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause 2001, 8, 259–265.
24. Nestel, P.J.; Pomeroy, S.; Kay, S.; Komesaroff, P.; Behrsing, J.; Cameron, J.D.; West, L. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J. Clin. Endocrinol. Metab. 1999, 84 (3), 895–898.
25. Teede, H.J.; McGrath, B.P.; DeSilva, L.; Cehun, M.; Fassoulakis, A.; Nestel, P.J. Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women. Arter-ioscler. Thromb. Vasc. Biol. 2003, 23, 1066–1071.
26. Baber, R.; Bligh, P.C.; Fulcher, G.; Liberman, D.; Nery, L.; Moreton, T. The effect of an isoflavone dietary supplement (Rimostil™) on serum lipids, forearm bone density and endometrial thickness in post-menopausal women, 10th Annual Meeting of the North American Menopause Society, Sept 23–25, 1999; The North American Menopause Society: New York, NY, 1999.
27. Howes, J.B.; Sullivan, D.; Lai, N.; Nestel, P.; Pomeroy, S.; West, L.; Eden, J.A.; Howes, L.G. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolemia. Atherosclerosis 2000, 152, 143–147.
28. Nestel, P.; Cehun, M.; Chronopoulos, A.; DaSilver, L.; Teede, H.; McGrath, B. A biocha-nin-enriched isoflavone from red clover lowers LDL cholesterol in men. Eur. J. Clin. Nutr. 2004, 58, 403–408.
29. Ko, R.J. Adulterants in Asian patent medicines. N. Engl. J. Med. 1998, 339, 847
30. Au, A.M.; Ko, R.; Boo, F.O.; Hsu, R.; Perez, G.; Yang, Z. Screening methods for drugs and heavy metals in Chinese patent medicines. Bull. Environ. Contam. Toxicol. 2000, 65, 112–119.
31. General Chapter: chemical tests and assays. In The United States Pharmacopeia Revision 27— The National Formulary Edition 22; United States Pharmacopoeial Convention, Inc.; Rock-ville, MD, 2003; 2233–2239.
32. Stahmann, M.A.; Huebner, C.F.; Link, K.P. Studies on the hemorrhagic sweet clover disease: V. Identification and synthesis of the hemorrhagic agent. J. Biol. Chem. 1941, 138, 513–527.
33. Horn-Ross, P.L.; Hoggatt, K.J.; Lee, M.M. Phytoestrogens and thyroid cancer risk: The San Francisco bay area thyroid cancer study. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 43–49.
34. American Herbal Products Association’s Botanical Safety Handbook; McGuffin, M., Hobbs, C., Upton, R., Goldberg, A., Eds.; CRC Press: New York, 1997; 117.
35. http:///www.tga.health.gov.au/docs/html/tganews/news28/chem.htm (accessed April 2004).
36. British Herbal Compendium; Bradley, P.R., Ed.; British Herbal Medicine Association; Biddles, Ltd., Guilford and King’s Lynn: Great Britain, 1992; Vol. 1, 183–184.
37. British Herbal Pharmacopoeia; 4th Ed.; British Herbal Medicine Association; Biddles, Ltd., Guilford and King’s Lynn: Great Britain, 1996; 160–161.
38. Martindale: The Extra Pharmacopoeia; 30th Ed.; Reynolds, J.E.F., Ed.; The Pharmaceutical Press: London, 1993; 1872.
39. http://www.legislation.hmso.gov.uk/si/si1994/Uksi_19942410_en_1.htm#tcon (accessed April 2004).
40. Howes, J.B.; Bray, K.; Lorenz, L.; Smerdely, P.; Howes, L.G. The effects of dietary supplementation with isoflavones from red clover on cognitive function in postmenopausal women. Climacteric 2004, 7, 70–77.
41. Schult, T.M.K.; Ensrud, K.E.; Blackwell, T.; Ettinger, B.; Wallace, R.; Tice, J.A. Effect of iso-flavones on lipids and bone turnover markers in menopausal women. Maturitas 2004, 48, 209–218.
42. Campbell, M.J.; Woodside, J.V.; Honour, J.W.; Morton, M.S.; Leathem, A.J.C. Effect of red clover-derived isoflavone supplementation on insulin-like growth factor, lipid and antioxidant status in healthy female volunteers: a pilot study. Eur. J. Clin. Nutr. 2004, 58, 173–179.
43. Atkinson, C.; Oosthuizen, W.; Scollen, S.; Loktionov, A.; Day, N.E.; Bingham, S.A. Modest protective effect of isoflavones from a red clover-derived dietary supplement on cardiovascular disease risk factors in perimenopausal women, and evidence of an interaction with ApoE genotype in 49–65 year-old women. J. Nutr. 2004, 134, 1759–1764.